What is Sanofi Consumer Healthcare India Net Margin %?
Sanofi Consumer Healthcare IndiaNSE:SANOFICONR -0.22%21 Net Margin % is 29.58% as of Mar. 2026, which is 8% above its 10-year median of 27.35. GuruFocus rates NSE:SANOFICONR with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 953 Drug Manufacturers companies, Sanofi Consumer Healthcare India ranks better than 93.18% on this metric.
The historical rank and industry rank for Sanofi Consumer Healthcare India's Net Margin % or its related term are showing as below:
NSE:SANOFICONR'
s Net Margin % Range Over the Past 10 Years
Min: 25.27 Med: 27.35 Max: 30.3
Current: 27.58
NSE:SANOFICONR's Net Margin % is ranked better than 93.18% of 953
companies
in the Drug Manufacturers industry
Industry Median: 5.69
vs NSE:SANOFICONR: 27.58
Sanofi Consumer Healthcare India (NSE:SANOFICONR) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Sanofi Consumer Healthcare India Net Margin % Related Terms
Sanofi Consumer Healthcare India Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India Net Margin % Chart
NSE:SANOFICONR vs LLY, JNJ, ABBV: Net Margin % Comparison
For the Drug Manufacturers - General subindustry, Sanofi Consumer Healthcare India's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanofi Consumer Healthcare India Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanofi Consumer Healthcare India's Net Margin % distribution charts can be found below:
* The bar in red indicates where Sanofi Consumer Healthcare India's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a Net Margin % of 29.58% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Sanofi Consumer Healthcare India and its competitors. This is near median its historical median of 27.35. Over the past decade, Sanofi Consumer Healthcare India's Net Margin % has ranged from 25.27 to 30.30. According to the industry distribution chart, Sanofi Consumer Healthcare India ranks #65 out of 953 companies in the Drug Manufacturers industry, placing it in the top 6.8%.
Is Sanofi Consumer Healthcare India's Net Margin % too high?
Sanofi Consumer Healthcare India's current Net Margin % of 29.58% is near median its 10-year median of 27.35. Over the past 10 years, this metric has ranged from a low of 25.27 to a high of 30.30. The Drug Manufacturers industry median Net Margin % is 5.69. Sanofi Consumer Healthcare India's value of 29.58% is 419.9% above this industry median. Based on the distribution chart, Sanofi Consumer Healthcare India ranks #65 out of 953 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sanofi Consumer Healthcare India has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Sanofi Consumer Healthcare India's Net Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sanofi Consumer Healthcare India ranks #65 out of 953 companies for Net Margin %. This places Sanofi Consumer Healthcare India in the top 7% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.69. Sanofi Consumer Healthcare India's value of 29.58% is 419.9% above this benchmark. Historically, Sanofi Consumer Healthcare India's own Net Margin % has ranged from 25.27 to 30.30 over the past decade. While the company's 10-year median is 27.35 vs. the industry median of 5.69, Sanofi Consumer Healthcare India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanofi Consumer Healthcare India's current Net Margin % of 29.58% is 419.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sanofi Consumer Healthcare India and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanofi Consumer Healthcare India's current Net Margin % is 29.58%, which is near median its own 10-year median of 27.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanofi Consumer Healthcare India stock overvalued right now?
Sanofi Consumer Healthcare India (NSE:SANOFICONR) has a current Net Margin % of 29.58%. The current Net Margin % is 29.58%, which is near median its 10-year median of 27.35 and 419.9% above the Drug Manufacturers industry median of 5.69. Sanofi Consumer Healthcare India's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sanofi Consumer Healthcare India (NSE:SANOFICONR), the current Net Margin % is 29.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sanofi Consumer Healthcare India Business Description
Sanofi Consumer Healthcare India Ltd is mainly engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/third-party manufacturers based across the country and provides business support services to its group entity in India. Its products include Allergy Relief (Allegra), Pain Care (Combiflam), and Physical Wellness (DePURA). The Company sells its products in India through independent distributors and outside India. Its operations are limited to one segment, namely Pharmaceutical Business. The Company operates in India, which generates the maximum revenue, and Outside India.
21GF Score
Get the complete analysis for NSE:SANOFICONR
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SANOFICONR has been successfully added to your 
